1.890USD0.00%Mkt Cap: 93.85M USDP/E: —Last update: 2026-06-01
iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company's technology platforms include Eng…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap93.85M USD
Enterprise Value21.92M USD
Revenue (TTM)300.00K USD
Gross Profit300.00K USD
Net Income (TTM)-18.38M USD
Revenue/Share0.0040 USD
Last Price1.890 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees20
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS4510336096
Valuation
P/E (Trailing)—
P/E (Forward)-6.01
PEG—
EV/EBITDA-0.78
EV/Revenue73.06
P/S314.63
P/B0.85
EPS (TTM)-0.56
EPS (Forward)-0.32
52W Range
0.560041% of range3.820
52W High3.820 USD
52W Low0.5600 USD
Profitability
Gross Margin100.00%
Oper. Margin-9653.00%
EBITDA Margin0.00%
Profit Margin-4594.25%
ROE-123.50%
ROA-79.26%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.30M USD
CapEx (TTM)16.00K USD
FCF Margin-4978.92%
FCF Yield-15.92%
Net Debt-72.47M USD
Net Debt/EBITDA2.56
Balance Sheet
Debt/Equity0.24
Current Ratio11.88
Quick Ratio11.50
Book Value/Sh2.245 USD
Cash/Share1.506 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 11, 2018
Splits
Last Split1:20
Split DateNov 29, 2023
Analyst Consensus
Rating—
Target (Mean)5.533 USD
Target Range4.200 USD – 7.000 USD
# Analysts6
Ownership
Shares Out.49.68M
Float39.32M
Insiders1.71%
Institutions46.88%
Short Interest
Short Ratio3.4d
Short % Float6.90%
Short % Out.6.86%
Shares Short3.41M
Short (prev mo.)3.64M
Technical
SMA 501.859 (+1.6%)
SMA 2001.652 (+14.4%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)905.56K
Avg Vol (10d)787.42K
Technical Indicators
RSI (14)55.7
MACD0.0064
MACD Signal-0.0495
MACD Hist.+0.0560
BB Upper1.996 USD
BB Middle1.683 USD
BB Lower1.369 USD
BB Width37.27%
ATR (14)0.1409 USD
Vol Ratio (20d)0.27x